Shuping Zhong Selected Research

N-n-butyl haloperidol iodide

1/2019	N-n-Butyl Haloperidol Iodide Ameliorates Oxidative Stress in Mitochondria Induced by Hypoxia/Reoxygenation through the Mitochondrial c-Jun N-Terminal Kinase/Sab/Src/Reactive Oxygen Species Pathway in H9c2 Cells.
1/2018	N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells.
6/2016	N-n-butyl haloperidol iodide ameliorates hypoxia/reoxygenation injury through modulating the LKB1/AMPK/ROS pathway in cardiac microvascular endothelial cells.
1/2016	N-n-butyl Haloperidol Iodide Protects against Hypoxia/Reoxygenation Injury in Cardiac Microvascular Endothelial Cells by Regulating the ROS/MAPK/Egr-1 Pathway.
9/2015	N-n-butyl haloperidol iodide protects cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy.
7/2015	Effect of N-n-butyl haloperidol iodide on ROS/JNK/Egr-1 signaling in H9c2 cells after hypoxia/reoxygenation.
1/2013	N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuping Zhong Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 06/2004
8	Breast Neoplasms (Breast Cancer) 07/2020 - 01/2013
7	Hypoxia (Hypoxemia) 01/2019 - 01/2013
6	Carcinogenesis 01/2018 - 08/2009
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2013
4	Rheumatoid Arthritis 11/2022 - 01/2014
3	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 01/2007
3	Reperfusion Injury 01/2016 - 01/2013
2	Ankylosing Spondylitis 07/2022 - 04/2022
2	Stomach Neoplasms (Stomach Cancer) 11/2018 - 01/2018
2	Granuloma 01/2016 - 01/2014
2	Edema (Dropsy) 01/2016 - 01/2014
1	Non-Radiographic Axial Spondyloarthritis 07/2022
1	Inflammation (Inflammations) 07/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 06/2019
1	Infections 01/2016
1	Schistosomiasis japonica 01/2016
1	Ischemia 09/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014
1	Arthritis (Polyarthritis) 01/2014
1	Pleurisy (Pleuritis) 01/2014
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Coffin-Lowry Syndrome (Syndrome, Coffin-Lowry) 07/2002

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 05/2020 - 08/2009
9	RNA Polymerase IIIIBA 01/2020 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
7	5S Ribosomal RNAIBA 01/2020 - 01/2013
7	N-n-butyl haloperidol iodideIBA 01/2019 - 01/2013
5	Estrogen ReceptorsIBA 05/2020 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2009
4	Transcription Factors (Transcription Factor)IBA 05/2020 - 07/2015
4	Transcription Factor TFIIB (TFIIB)IBA 05/2020 - 02/2016
3	Transcription Factor TFIIIBIBA 01/2019 - 11/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 07/2015
3	tributyl phosphate (TBP)IBA 08/2013 - 06/2004
3	Phosphotransferases (Kinase)IBA 08/2009 - 07/2002
2	Circular RNAIBA 10/2021 - 01/2020
2	Ethanol (Ethyl Alcohol)IBA 06/2019 - 02/2016
2	Haloperidol (Haldol)FDA LinkGeneric 01/2018 - 09/2015
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2018 - 08/2009
2	Small Interfering RNA (siRNA)IBA 12/2017 - 02/2015
2	Tamoxifen FDA LinkGeneric 12/2017 - 12/2014
2	Biological ProductsIBA 02/2016 - 01/2013
2	Croton OilIBA 01/2016 - 01/2014
1	C-Reactive ProteinIBA 07/2022
1	ProcollagenIBA 07/2022
1	Peptides (Polypeptides)IBA 07/2022
1	Adalimumab (Humira)FDA Link 04/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Methylnitronitrosoguanidine (MNNG)IBA 01/2021
1	Betaine (C.B.B.)FDA Link 07/2020
1	LuciferasesIBA 05/2020
1	ChromatinIBA 05/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	SirtuinsIBA 01/2020
1	JNK Mitogen-Activated Protein KinasesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2018
1	Interleukin-8 (Interleukin 8)IBA 11/2018
1	Interleukin-10 (Interleukin 10)IBA 11/2018
1	ORALIT (ORS)IBA 11/2018
1	InterleukinsIBA 11/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Transfer RNA (tRNA)IBA 12/2017
1	Interleukin-33IBA 01/2016
1	Leu Transfer RNAIBA 02/2015
1	Bile Acids and Salts (Bile Acids)IBA 01/2015
1	Pregnane X ReceptorIBA 05/2014
1	CarrageenanIBA 01/2014
1	Freund's AdjuvantIBA 01/2014
1	1-Butanol (n Butanol)IBA 01/2014
1	CalciumIBA 01/2013
1	Calcium Channels (Calcium Channel)IBA 01/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2008
1	LipidsIBA 06/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2008
1	ErbB Receptors (EGF Receptor)IBA 06/2004
1	tyrosine receptor (receptor, tyrosine)IBA 06/2004
1	Serine (L-Serine)FDA Link 07/2002

Therapy/Procedure

1	Therapeutics 04/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014
1	Oral Administration 01/2014